APS Logo

AI in Medicine

INVITED · APR-P02 · ID: 2684369

Presentations

  • AI for Clinical Trials and Precision Medicine

    ORAL · Invited

    –

    Publication: 1. Liu, Ruishan, et al. "Evaluating eligibility criteria of oncology trials using real-world data and AI." Nature 592.7855 (2021): 629-633.<br>2. Liu, Ruishan, et al. "Systematic pan-cancer analysis of mutation–treatment interactions using large real-world clinicogenomics data." Nature Medicine 28.8 (2022): 1656-1661.<br>3. Liu, Ruishan, et al. "Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients." Cell Reports Medicine 5.3 (2024).<br>4. Liu, Ruishan, et al. "Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers." Nature Communications 15.1 (2024): 10884.

    Presenters

    • Ruishan Liu

      University of Southern California

    Authors

    • Ruishan Liu

      University of Southern California

    View abstract →